At this year’s SCOPE Summit, Quan Doan, Vice President of Technology Solutions at SDC, delivered a forward-looking session that captured a central truth shaping our industry: AI is no longer an add‑on—it is becoming the clinical data ecosystem itself.
For decades, clinical teams relied on dashboards and retrospective analytics to understand what happened yesterday. But today’s trials demand more. They require platforms that can see the present clearly, anticipate what comes next, and empower teams to act with confidence. That shift is exactly where SDC Insights™ 2.0 with SDC Sidekick™ AI is transforming the landscape.
In the 12‑minute Innovation Theater presentation below, Quan offers a concise, visionary view of what’s possible when AI becomes an integrated partner— not just a tool. Listen to the presentation or read the highlights below:
Clinical development is at a pivotal moment. The volume, diversity, and velocity of data have grown far beyond what traditional tools—and even traditional teams—were designed to manage. AI adoption is accelerating across the industry, but organizations still face barriers:
• Concern about regulatory readiness
• Uncertainty about model transparency
• Lack of clinically trained systems
• Hesitation to trust AI‑generated outputs without verification
SDC is addressing these challenges by embedding AI directly into the foundation of the data oversight platform—not layered on top but built in from the start. This structural approach supports real‑time insights, regulatory defensibility, and human‑in‑the‑loop validation.
SDC Sidekick™ AI serves as a continuously engaged data steward—scanning for inconsistencies, identifying outliers, and surfacing issues that traditional edit checks simply miss. For data management leaders, this means:
• Earlier detection of physiological anomalies
• Identification of site‑level patterns and potential fraud
• Reduced manual effort in drafting and issuing queries
• Up to 60% time reduction in routine data cleaning tasks
And critically, with human‑in‑the‑loop validation, every AI‑generated output is fully reviewable and fully traceable.
The future of AI in clinical trials lies in agents—autonomous, specialized digital teammates that execute end‑to‑end workflows.
Quan previewed several capabilities on SDC’s near-term roadmap:
1. Generative UI
Imagine if you could ask SDC Sidekick AI a question and then get a visual as the output.
Sidekick will automatically generate charts, dashboards, and custom interfaces—no development request required.
2. Personalized AI Agents
Role‑specific agents could soon assist with tasks such as:
• SDTM transformations
• Safety narrative drafting
• External data ingestion
• Ongoing quality checks
These “workforce‑ready” agents will adapt to each organization’s processes, accelerating timelines from weeks to days.
For clinical leaders responsible for data quality, patient safety, and operational efficiency, the value is clear:
• AI built for regulatory scrutiny with comprehensive traceability
• Clinically trained models validated within a closed and secure environment
• Scalable architecture that evolves with ICH, FDA, and global expectations
• Customization without programming, enabling teams to innovate directly
• Future‑ready platform designed to adapt to the industry—not chase it
SDC’s mission has always been to empower better clinical decisions. With Insights 2.0 with SDC Sidekick AI, that empowerment is now both real‑time and future‑proof.
Ready to learn more? Book a demo of SDC Insights™ 2.0 with Sidekick™ AI.
SDC celebrates 20 years of empowering clinical decisions. Discover our journey from a biometrics CRO to a fully tech-enabled CRO—and learn how SDC...
Discover how clinical program biostatistics and patient profiles improve clinical trial data management, leveraging electronic data capture, AI, and...
Explore how SDC Capture’s BYOD ePRO solution transforms clinical trials with seamless integration, enhanced engagement, and cost efficiency. Read...